Filing Details

Accession Number:
0001225208-15-020389
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-11-04 16:48:18
Reporting Period:
2015-11-02
Filing Date:
2015-11-04
Accepted Time:
2015-11-04 16:48:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1099800 Edwards Lifesciences Corp EW Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 364316614
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1308771 B Patrick Verguet One Edwards Way
Irvine CA 92614
Cvp, Europe No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-11-02 2,000 $31.47 51,901 No 4 M Direct
Common Stock Disposition 2015-11-02 2,000 $158.41 49,901 No 4 S Direct
Common Stock Acquisiton 2015-11-03 2,338 $31.47 52,239 No 4 M Direct
Common Stock Disposition 2015-11-03 2,338 $158.53 49,901 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Acquire) Disposition 2015-11-02 2,000 $31.47 2,000 $31.47
Common Stock Employee Stock Option (Right to Acquire) Disposition 2015-11-03 2,338 $31.47 2,338 $31.47
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
22,338 2010-05-07 2016-05-06 No 4 M Direct
20,000 2010-05-07 2016-05-06 No 4 M Direct
Footnotes
  1. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
  2. This transaction was executed in multiple trades at prices ranging from $158.40 to $158.45. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.